Creating a partnership to improve treatments for long COVID
Official title: Establishment of a Public-Private Partnership (PPP) to Support Therapy Selection and Testing within RECOVER-TLC
Funded at Foundation for the NIH · NIH-11194672 · Data updated 2026-11-12
This study is working to bring together different groups, like researchers and health officials, to speed up the creation of new treatments for long COVID-19, so that patients can have better access to helpful therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Foundation for the NIH NIH-funded |
| Lab location | 1 site (North Bethesda, UNITED STATES) |
| Project start | September 25, 2024 |
| Project end | September 24, 2025 |
| Funding year | 2024 |
| Award (this year) | $3,255,169 |
| NIH project number | 1OT2OD039735-01 |
| Project ID | NIH-11194672 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals experiencing long COVID symptoms who are seeking new treatment options.
✕Less likely to help
Patients who do not have long COVID or are not experiencing related symptoms may not benefit from this research.
What this research studies
This research aims to establish a public-private partnership to enhance the development of therapies for long COVID-19. By collaborating with various stakeholders, including biomedical researchers and the FDA, the project seeks to create a coordinated approach to tackle the challenges associated with long COVID. Patients may benefit from improved access to innovative treatments as the partnership works to accelerate therapeutic development. The methodology involves strategic planning and collaboration across sectors to ensure effective solutions are identified and implemented.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective therapies for long COVID, improving patient outcomes.
How similar studies have gone: Previous collaborations in similar public-private partnerships have shown promise in accelerating therapeutic development for various conditions, suggesting a potential for success in this novel approach.
Where this research is happening
-
Foundation for the NIH
North Bethesda, United States Active
Researchers
- Principal investigator: Adam, Stacey — Foundation for the NIH
- Study coordinator: Adam, Stacey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.